On August 29, the production workshop of Heilongjiang Unicornshell Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of Shanghai Unicornshell Pharmaceutical Technology Co., Ltd., successfully reached its structural completion, marking a new phase in the project's development. This milestone represents the first construction project to reach topping-out within Unicornshell's Northeast industrial cluster strategy, carrying significant strategic importance. Phase I of the project is expected to be completed and commence production by the end of 2025.

 01 Heilongjiang Project: A Key Strategic Move

Located in Keshan County, Qiqihar City, the Heilongjiang Unicornshell project is a vital component of Unicornshell's Northeast industrial cluster strategy, slated for production launch by the end of 2025. With the production workshop topping out, the manufacturing base construction is progressing as planned, providing robust support for Quanjikang's future capacity expansion and market expansion.

02 Unicornshell Embarking on a New Chapter of Industrial Upgrading

Innovation-Driven Industrial Transformation

Headquartered in Shanghai, Unicornshell specializes in the R&D, production, and sales of plant-based pharmaceutical excipients and innovative traditional Chinese medicine formulations, striving to become a leader in intelligent manufacturing of plant-based capsules. Through its industrial cluster model, the company promotes the deep integration of smart manufacturing and new materials, empowering the transformation of traditional pharmaceutical industries while advancing green medicine and the modernization of traditional Chinese medicine.

Steady Progress in Modernization

The new fully automated GMP production workshop at the Heilongjiang base is advancing according to schedule. The completion of the workshop roof marks a new phase in the project's construction. This steady progress provides a solid foundation for subsequent equipment installation, debugging, and production preparation. Phase I is expected to be completed and operational by the end of this year.

03 Future Outlook: Green and Intelligent Development

With the successful topping out of the production workshop, Unicornshell will continue to deepen its “green, safe, and intelligent” strategy, driving the upgrade of the green pharmaceutical industry and contributing to global health initiatives. The company will leverage innovation as a driving force to further advance its industrial layout and consistently lead the development of the green pharmaceutical sector.